Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 369 record(s)

Req # A-2022-001500

Adverse Drug Reaction (ADR) for MORPHINE. Report number: 001019927. ADRs for HEPARIN AI. Report numbers: E2B_05991667, E2B_06019838, E2B_06023997.

Organization: Health Canada

109 page(s)
September 2023

Req # A-2022-001520

Adverse Drug Reactions (ADRs) for MESALAZINE. Report numbers: 001022111, 001022820, 001022749, 001023019, 001022984. ADRs for MESALAMINE. Report numbers: E2B_05978116, E2B_05990113, E2B_05960176, E2B_06023958.

Organization: Health Canada

82 page(s)
September 2023

Req # A-2022-001553

Adverse Drug Reactions (ADRs). Report numbers: 001023620, E2B_06033606, E2B_06074495, E2B_06033839, E2B_06041914, E2B_06057050.

Organization: Health Canada

69 page(s)
September 2023

Req # A-2022-001567

Adverse Drug Reactions (ADRs). Report numbers: E2B_05945826, E2B_05596175.

Organization: Health Canada

15 page(s)
September 2023

Req # A-2022-001628

Adverse Drug Reactions (ADRs). Report numbers: E2B_04181613, 001022925, E2B_05672092.

Organization: Health Canada

16 page(s)
September 2023

Req # A-2022-001661

Adverse Drug Reaction (ADR). Report number: E2B_05716216.

Organization: Health Canada

11 page(s)
September 2023

Req # A-2022-001672

Adverse Drug Reactions (ADRs). Report numbers: E2B_05432687, 001012426, E2B_05458725, 000997976, E2B_06093479, E2B_05334927, E2B_05374888, E2B_05382158, E2B_05441385.

Organization: Health Canada

440 page(s)
September 2023

Req # A-2023-000002

Adverse Drug Reactions (ADRs). Report numbers: E2B_04604447, E2B_04921453, 000737093, E2B_02795460, E2B_02948829, E2B_02964838, E2B_03052613, 000922333, E2B_03456254, E2B_03496139.

Organization: Health Canada

180 page(s)
September 2023

Req # A-2023-000092

Adverse Drug Reactions (ADRs). Report numbers: E2B_03906058, 000947487, 000948608, 000950448, 000953437, 000950500, 000954648, 000959742, 000961076, 000961054.

Organization: Health Canada

162 page(s)
September 2023

Req # A-2023-000111

Adverse Drug Reactions (ADRs). Report numbers: 001018068, 001024889, E2B_01299621, E2B_02291085, E2B_04920318, E2B_05539794, E2B_05568656, E2B_05945050, E2B_02292111, E2B_00803866.

Organization: Health Canada

1894 page(s)
September 2023
Date modified: